Full-Time

Senior Technical Manager

Updated on 8/18/2026

Deadline 8/25/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$118.5k - $260.6k/yr

+ Bonus + Commission + Short-term incentive + Equity award

Company Historically Provides H1B Sponsorship

Connecticut, USA + 4 more

More locations: Texas, USA | Rhode Island, USA | New York, NY, USA | Massachusetts, USA

Remote

Bachelor's

Category
Engineering Management (1)
Required Skills
LLM
Kubernetes
Agile
Python
React.js
Git
BigQuery
SQL
Apache Kafka
Java
Postgres
RDBMS
SAP Products
Docker
Risk Management
REST APIs
Google Cloud Platform

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • Seven or more years of information technology experience focused on engineering, software architecture, and development.
  • Seven or more years of experience supporting or providing technical oversight for SAP BW reporting solutions, including Advanced DataStore Objects, CompositeProviders, transformations, Data Transfer Processes, Process Chains, BW queries, data load monitoring, and source-to-target validation.
  • Three or more years of required experience with Google Cloud Platform and BigQuery reporting, including designing, developing, and supporting scalable reporting solutions.
  • Five or more years of experience with SQL and database performance tuning, including query optimization, indexing and partitioning strategies, execution plan analysis, and performance troubleshooting for enterprise reporting and reconciliation workloads.
  • Experience leading or supporting mission-critical reporting, reconciliation, or transaction-processing platforms that process millions of records or transactions per day, with accountability for scalability, reliability, operational controls, and production support.
  • Five or more years of experience recruiting, managing, and retaining a high-performing team of software development professionals in an agile environment.
  • Three or more years of using generative artificial intelligence as an integrated component in software solutions.
  • A bachelor's degree or equivalent in Computer Science, Information Systems, Engineering, or a related field.
Responsibilities
  • Provide technical direction, evaluate solution design quality, and ensure teams deliver scalable, resilient, high-value solutions aligned to business, operational, audit, and enterprise architecture needs.
  • Monitor and optimize application, reporting, database, and data pipeline performance for high-volume transaction environments, including throughput, query performance, data load windows, latency, reliability, resiliency, and operational service-level agreements.
  • Recruit, manage, mentor, and retain a high-performing engineering team while contributing to a positive and supportive culture, encouraging innovation, and balancing continuous improvement with effective value delivery.
  • Collaborate with engineering, platform, design, security, and audit teams to understand expectations and develop solutions in accordance with appropriate guidelines.
  • Identify, communicate, and mitigate internal and external risks, and present technical concepts to non-technical stakeholders.
  • Stay updated on industry trends, emerging technologies, and best practices in software development, analytics, and artificial intelligence technologies.
Desired Qualifications
  • Ability to diagram complex software architectures and communicate complex engineering ideas to non-technical stakeholders visually and verbally.
  • Strong experience with React, API Platform, and full-cycle development from strategy through execution.
  • Strong understanding of cloud-based technologies, including Google Cloud Platform, engineering frameworks, and tools.
  • Familiarity with continuous integration and continuous delivery, cloud DevOps, containers such as Kubernetes and Docker, and Google Cloud Platform managed services.
  • Experience in large retail or pharmacy environments.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
  • CVS and Eli Lilly launch Zepbound and Foundayo pricing in-app by early Q4 2026.
  • CVS opened pharmacy-focused Houston stores and plans nearly 20 nationwide openings.

What critics are saying

  • Reuters said Caremark expects weaker client retention after August 5, 2026 results.
  • Louisiana settled three PBM lawsuits with CVS for $45 million on February 20, 2026.
  • Tennessee's FAIR Rx Act threatens 137 CVS pharmacies and MinuteClinics, risking forced divestiture.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies across U.S. scale.
  • August 5, 2026 results showed all three segments beat revenue expectations.
  • Teresa Heitsenrether joins the board November 18, 2026, signaling data-driven healthcare execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

Yahoo Finance
Aug 11th, 2026
AbbVie acquires Apogee Therapeutics for $10.9B amid pipeline expansion

AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.

Yahoo Finance
Aug 5th, 2026
CVS Health Q2 earnings beat expectations, partners with Eli Lilly on weight loss drugs

CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.